BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28032675)

  • 1. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
    McGaugh S; Kallis P; De Benedetto A; Thomas RM
    Dermatol Ther; 2022 Jun; 35(6):e15437. PubMed ID: 35278019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized morphea: a case report.
    Payapvipapong K; Aunhachoke K
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S215-7. PubMed ID: 21280538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphea and other localized forms of scleroderma.
    Vasquez R; Sendejo C; Jacobe H
    Curr Opin Rheumatol; 2012 Nov; 24(6):685-93. PubMed ID: 23018858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
    Mizutani H; Yoshida T; Nouchi N; Hamanaka H; Shimizu M
    J Dermatol; 1999 Jan; 26(1):11-7. PubMed ID: 10063206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of scleroderma.
    Adnan ZA
    Acta Med Indones; 2008 Apr; 40(2):109-12. PubMed ID: 18560030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.
    Hulshof MM; Bouwes Bavinck JN; Bergman W; Masclee AA; Heickendorff L; Breedveld FC; Dijkmans BA
    J Am Acad Dermatol; 2000 Dec; 43(6):1017-23. PubMed ID: 11100017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of morphea and psoriasis responding to acitretin treatment.
    Bilen N; Apaydin R; Erçin C; Harova G; Başdaş F; Bayramgürler D
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):113-7. PubMed ID: 10568490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and localized scleroderma in children: current and future treatment options.
    Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
    Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease.
    Sink JR; Chiu YE
    Pediatr Dermatol; 2021 Sep; 38(5):1020-1031. PubMed ID: 34272748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric morphea (localized scleroderma): review of 136 patients.
    Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
    J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.